Significant Publications on Infectious Diseases Pharmacotherapy in 2022
Journal of Pharmacy Practice · 2024
DOI: 10.1177/08971900231194200 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pharmacy Practice, 2024. Verfasst von Nicholas Teran und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, CHI Baylor St Luke's Medical Center, Houston, TX, USA. Hauptthemen laut MEDLINE: Communicable Diseases, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 101 Literaturangaben.
Abstract (Originalsprache)
Purpose
To provide summarization of the most significant infectious diseases (ID) pharmacotherapy articles published in peer-reviewed literature in 2022. Summary: Members of the Houston Infectious Diseases Network (HIDN) nominated notable articles providing significant contributions to ID pharmacotherapy in 2022. Article nominations included those pertaining to general ID, as well as those including coronavirus disease 2019 (COVID-19), and human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) pharmacotherapy. A total of 71 articles were nominated by HIDN. Members: 68 articles pertaining to general ID pharmacotherapy and 3 articles focusing on HIV/AIDS. To aid selection of the most these most notable articles of 2022, a survey was created and distributed to members of the Society of Infectious Diseases Pharmacists (SIDP). Of the 153 SIDP members who participated in the survey, there were 128 recorded votes for the top 10 general ID pharmacotherapy articles and 30 votes recorded for the top HIV/AIDS article. The most notable publications are summarized.
Conclusion
Post pandemic significant advances in antimicrobial stewardship and infectious disease states continues to occur in a world recently focused on the coronavirus disease 2019 (COVID-19) global pandemic. Continuous growth in publication of ID-related articles over the past year lends towards the aims of this review to aid clinicians in remaining current on key practice-changing ID pharmacotherapy publications from 2022.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, CHI Baylor St Luke's Medical Center, Houston, TX, USA.
- Department of Pharmacy, The University of Texas Medical Branch, Galveston, TX, USA.
- Department of Pharmacy, Houston Methodist Hospital, Houston, TX, USA.
- Department of Pharmacy, Memorial Hermann Southwest, Houston, TX, USA.
- Department of Pharmacy, Memorial Hermann Katy Hospital, Katy, TX, USA.
- Department of Pharmacy, HCA Houston Healthcare Clear Lake, Webster, TX, USA.
ORCID-Profile: Nicholas Teran, Kelsey Olson, Stefanie Stramel
Zitieren
APA
Teran, N., Buckley, V., Britt, R. S., Ikwuagwu, J., Thomas, J. L., Zaki, A., Olson, K., Stramel, S., & Houston Infectious Diseases Network (2024). Significant Publications on Infectious Diseases Pharmacotherapy in 2022. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900231194200
Vancouver
Teran N, Buckley V, Britt RS, Ikwuagwu J, Thomas JL, Zaki A, et al. Significant Publications on Infectious Diseases Pharmacotherapy in 2022. Journal of Pharmacy Practice. 2024. doi:10.1177/08971900231194200
BibTeX
@article{Teran2024,
author = {Teran, Nicholas and Buckley, Valerie and Britt, Rachel S and Ikwuagwu, Judy and Thomas, Jamie L and Zaki, Amir and Olson, Kelsey and Stramel, Stefanie and Houston Infectious Diseases Network, Houston Infectious Diseases Network},
title = {Significant Publications on Infectious Diseases Pharmacotherapy in 2022},
journal = {Journal of Pharmacy Practice},
year = {2024},
doi = {10.1177/08971900231194200}
}
EUVIMED